Found: 29
Select item for more details and to access through your institution.
Trends in the appropriateness of oral antibiotic prescriptions dispensed in the United States from 2010 to 2018.
- Published in:
- Pharmacotherapy, 2024, v. 44, n. 9, p. 701, doi. 10.1002/phar.4604
- By:
- Publication type:
- Article
Utilization of cefepime therapeutic drug monitoring in febrile neutropenia patients with hematologic malignancies.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1207, doi. 10.1177/10781552231213883
- By:
- Publication type:
- Article
Resource Over-Utilization in Hospitalized Patients With Uncomplicated Skin and Soft Tissue Infections.
- Published in:
- Journal of Pharmacy Practice, 2022, v. 35, n. 5, p. 675, doi. 10.1177/08971900211000216
- By:
- Publication type:
- Article
Use of an Anti-Infective Medication Review Process at Hospital Discharge to Identify Medication Errors and Optimize Therapy.
- Published in:
- Journal of Pharmacy Practice, 2019, v. 32, n. 5, p. 488, doi. 10.1177/0897190018761411
- By:
- Publication type:
- Article
Preparing Students to Enter the Race for Postgraduate Training.
- Published in:
- Journal of Pharmacy Practice, 2017, v. 30, n. 4, p. 476, doi. 10.1177/0897190016645033
- By:
- Publication type:
- Article
Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant Enterobacterales and Pseudomonas aeruginosa.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 8, p. 1, doi. 10.1093/ofid/ofab371
- By:
- Publication type:
- Article
Real-world Multicenter Analysis of Clinical Outcomes and Safety of Meropenem-Vaborbactam in Patients Treated for Serious Gram-Negative Bacterial Infections.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 3, p. N.PAG, doi. 10.1093/ofid/ofaa051
- By:
- Publication type:
- Article
1548. Characterizing Cefepime Neurotoxicity: Experience from a Tertiary Care Center Performing β-lactam Therapeutic Drug Monitoring.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S565, doi. 10.1093/ofid/ofz360.1412
- By:
- Publication type:
- Article
Regulatory Oversight and Safety of Probiotic Use.
- Published in:
- Emerging Infectious Diseases, 2010, v. 16, n. 11, p. 1661, doi. 10.3201/eid1611.100574
- By:
- Publication type:
- Article
Impact of an antimicrobial stewardship initiative on time to administration of empirical antibiotic therapy in hospitalized patients with bacteremia.
- Published in:
- American Journal of Health-System Pharmacy, 2017, v. 74, n. 7, p. 511, doi. 10.2146/ajhp160096
- By:
- Publication type:
- Article
Training a Drug to Do New Tricks: Insights on Stability of Meropenem Administered as a Continuous Infusion.
- Published in:
- Microbiology Insights, 2018, v. 11, p. 1, doi. 10.1177/1178636118804549
- By:
- Publication type:
- Article
Implementation of a β-lactam therapeutic drug monitoring program: Experience from a large academic medical center.
- Published in:
- American Journal of Health-System Pharmacy, 2022, v. 79, n. 18, p. 1586, doi. 10.1093/ajhp/zxac171
- By:
- Publication type:
- Article
Selecting anti-infective agents for the treatment of bone infections: new anti-infective agents and chronic suppressive therapy.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Selecting Anti-infective Agents for the Treatment of Bone Infections: New Anti-infective Agents and Chronic Suppressive Therapy.
- Published in:
- Orthopedics, 2007, v. 30, n. 10, p. 832
- By:
- Publication type:
- Article
Selecting anti-infective agents for the treatment of bone infections.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Selecting Anti-infective Agents for the Treatment of Bone Infections.
- Published in:
- Orthopedics, 2007, v. 30, n. 9, p. 713
- By:
- Publication type:
- Article
Association of piperacillin and vancomycin exposure on acute kidney injury during combination therapy.
- Published in:
- JAC-Antimicrobial Resistance, 2024, v. 6, n. 1, p. 1, doi. 10.1093/jacamr/dlad157
- By:
- Publication type:
- Article
Re-evaluation of cefepime or piperacillin/tazobactam to decrease use of carbapenems in ESBL-producing Enterobacterales urinary tract infections (REDUCE-UTI).
- Published in:
- JAC-Antimicrobial Resistance, 2023, v. 5, n. 2, p. 1, doi. 10.1093/jacamr/dlad021
- By:
- Publication type:
- Article
Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents: Ceftolozane-Tazobactam vs Piperacillin-Tazobactam.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 3, p. e1444, doi. 10.1093/cid/ciac670
- By:
- Publication type:
- Article
Oral fluoroquinolones and risk of aortic aneurysm or dissection: A nationwide population‐based propensity score‐matched cohort study.
- Published in:
- Pharmacotherapy, 2023, v. 43, n. 9, p. 883, doi. 10.1002/phar.2841
- By:
- Publication type:
- Article
Use of therapeutic drug monitoring to characterize cefepime‐related neurotoxicity.
- Published in:
- Pharmacotherapy, 2023, v. 43, n. 1, p. 6, doi. 10.1002/phar.2744
- By:
- Publication type:
- Article
Trimethoprim-Sulfamethoxazole Exposure Alters Ex Vivo Function of B Lymphocytes Isolated from Human Immunodeficiency Virus-Infected Patients Receiving Zidovudine.
- Published in:
- Pharmacotherapy, 2009, v. 29, n. 4, p. 373, doi. 10.1592/phco.29.4.373
- By:
- Publication type:
- Article
Incidence of Antiretroviral Drug Interactions During Hospital Course: The Role of a Pharmacist-Led Antiretroviral Stewardship Program.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Brincidofovir for disease progression due to suspected tecovirimat resistance in association with advanced HIV.
- Published in:
- International Journal of STD & AIDS, 2024, v. 35, n. 8, p. 651, doi. 10.1177/09564624241238813
- By:
- Publication type:
- Article
Evaluation of Susceptibility Patterns in Uropathogens and Empiric Antibiotic Therapy in the Emergency Department.
- Published in:
- Hospital Pharmacy, 2021, v. 56, n. 6, p. 745, doi. 10.1177/0018578720957965
- By:
- Publication type:
- Article
Re-evaluation of cefepime or piperacillin-tazobactam to decrease use of carbapenems in extended-spectrum beta-lactamase-producing Enterobacterales bloodstream infections (REDUCE-BSI).
- Published in:
- Antimicrobial Stewardship & Healthcare Epidemiology, 2022, v. 2, n. 1, p. 1, doi. 10.1017/ash.2022.21
- By:
- Publication type:
- Article
Making the case for precision dosing: visualizing the variability of cefepime exposures in critically ill adults.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2170, doi. 10.1093/jac/dkad211
- By:
- Publication type:
- Article
Early therapeutic monitoring of β-lactams and associated therapy outcomes in critically ill patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Management of skin and soft-tissue infections at a community teaching hospital using a severity-of-illness tool.
- Published in:
- 2016
- By:
- Publication type:
- journal article